logo-loader
OTCQB:CNBX

Cannabics Pharmaceuticals Inc

Receive alerts
Market:
OTCQB
Price
0.01 USD
Day Change
5.64%
Market Cap:
$460.14 k
52 weeks high
0.10
52 weeks low
0.0097

In brief

Cannabics Pharmaceuticals Inc is the developer of the world’s first cannabinoid-based antitumor drug candidate for the treatment of colorectal cancer based on the company's novel and proprietary formulation Cannabics™️ RCC-33.

The company's groundbreaking research and development are carried out in its in-house state of the art drug discovery facilities using proprietary High Throughput Screening (HTS) technology and advanced bioinformatics.